CN104003903B - The synthetic method of sartanbiphenyl - Google Patents
The synthetic method of sartanbiphenyl Download PDFInfo
- Publication number
- CN104003903B CN104003903B CN201410201677.1A CN201410201677A CN104003903B CN 104003903 B CN104003903 B CN 104003903B CN 201410201677 A CN201410201677 A CN 201410201677A CN 104003903 B CN104003903 B CN 104003903B
- Authority
- CN
- China
- Prior art keywords
- water
- adds
- solid
- reaction
- add
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000010189 synthetic method Methods 0.000 title claims abstract description 5
- 239000000126 substance Substances 0.000 claims abstract 6
- ONIKNECPXCLUHT-UHFFFAOYSA-N 2-chlorobenzoyl chloride Chemical compound ClC(=O)C1=CC=CC=C1Cl ONIKNECPXCLUHT-UHFFFAOYSA-N 0.000 claims abstract 2
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 claims abstract 2
- 238000006243 chemical reaction Methods 0.000 claims description 28
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 25
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims description 24
- ZUOUZKKEUPVFJK-UHFFFAOYSA-N phenylbenzene Natural products C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 claims description 24
- 239000007787 solid Substances 0.000 claims description 24
- 238000003756 stirring Methods 0.000 claims description 24
- 239000000047 product Substances 0.000 claims description 18
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 claims description 17
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 14
- 239000004305 biphenyl Substances 0.000 claims description 13
- 235000010290 biphenyl Nutrition 0.000 claims description 13
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 claims description 12
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims description 11
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 10
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 9
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 9
- 238000002360 preparation method Methods 0.000 claims description 8
- -1 methyl Fluorenone Potassium hydroxide Chemical compound 0.000 claims description 7
- LPNYRYFBWFDTMA-UHFFFAOYSA-N potassium tert-butoxide Chemical compound [K+].CC(C)(C)[O-] LPNYRYFBWFDTMA-UHFFFAOYSA-N 0.000 claims description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 6
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 6
- 239000000203 mixture Substances 0.000 claims description 5
- 238000000926 separation method Methods 0.000 claims description 5
- 239000000243 solution Substances 0.000 claims description 5
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims description 4
- 235000011114 ammonium hydroxide Nutrition 0.000 claims description 4
- 238000001816 cooling Methods 0.000 claims description 4
- 239000000284 extract Substances 0.000 claims description 4
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 claims description 3
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 claims description 3
- VTHJTEIRLNZDEV-UHFFFAOYSA-L magnesium dihydroxide Chemical compound [OH-].[OH-].[Mg+2] VTHJTEIRLNZDEV-UHFFFAOYSA-L 0.000 claims description 3
- 239000000347 magnesium hydroxide Substances 0.000 claims description 3
- 229910001862 magnesium hydroxide Inorganic materials 0.000 claims description 3
- 238000010992 reflux Methods 0.000 claims description 3
- 239000007864 aqueous solution Substances 0.000 claims description 2
- 239000012065 filter cake Substances 0.000 claims description 2
- 239000000706 filtrate Substances 0.000 claims description 2
- 239000012074 organic phase Substances 0.000 claims description 2
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 claims description 2
- QCVMLXNTSUFLGI-UHFFFAOYSA-N 4-methylfluoren-9-one Chemical compound O=C1C2=CC=CC=C2C2=C1C=CC=C2C QCVMLXNTSUFLGI-UHFFFAOYSA-N 0.000 claims 5
- 238000010792 warming Methods 0.000 claims 3
- SCYULBFZEHDVBN-UHFFFAOYSA-N 1,1-Dichloroethane Chemical compound CC(Cl)Cl SCYULBFZEHDVBN-UHFFFAOYSA-N 0.000 claims 2
- ALLIZEAXNXSFGD-UHFFFAOYSA-N 1-methyl-2-phenylbenzene Chemical group CC1=CC=CC=C1C1=CC=CC=C1 ALLIZEAXNXSFGD-UHFFFAOYSA-N 0.000 claims 2
- 230000003292 diminished effect Effects 0.000 claims 2
- 235000019441 ethanol Nutrition 0.000 claims 2
- 238000000605 extraction Methods 0.000 claims 2
- 238000001914 filtration Methods 0.000 claims 2
- 238000010438 heat treatment Methods 0.000 claims 2
- 150000002576 ketones Chemical class 0.000 claims 2
- 238000001953 recrystallisation Methods 0.000 claims 2
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims 1
- 239000005864 Sulphur Substances 0.000 claims 1
- 239000012295 chemical reaction liquid Substances 0.000 claims 1
- YDVNLQGCLLPHAH-UHFFFAOYSA-N dichloromethane;hydrate Chemical compound O.ClCCl YDVNLQGCLLPHAH-UHFFFAOYSA-N 0.000 claims 1
- 238000004090 dissolution Methods 0.000 claims 1
- 238000003810 ethyl acetate extraction Methods 0.000 claims 1
- 238000006386 neutralization reaction Methods 0.000 claims 1
- 239000000376 reactant Substances 0.000 claims 1
- 239000002994 raw material Substances 0.000 abstract description 7
- 238000004519 manufacturing process Methods 0.000 abstract description 4
- 238000005863 Friedel-Crafts acylation reaction Methods 0.000 abstract description 3
- 239000003513 alkali Substances 0.000 abstract description 3
- 125000004093 cyano group Chemical group *C#N 0.000 abstract description 3
- 150000003839 salts Chemical class 0.000 abstract description 3
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract description 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract description 2
- 239000002699 waste material Substances 0.000 abstract description 2
- 238000007171 acid catalysis Methods 0.000 abstract 1
- FHIVAFMUCKRCQO-UHFFFAOYSA-N diazinon Chemical compound CCOP(=S)(OCC)OC1=CC(C)=NC(C(C)C)=N1 FHIVAFMUCKRCQO-UHFFFAOYSA-N 0.000 abstract 1
- 238000000034 method Methods 0.000 description 8
- FWPHKKLPYHVMDZ-UHFFFAOYSA-N 2-methylfluoren-1-one Chemical compound C1=CC=C2C3=CC=C(C)C(=O)C3=CC2=C1 FWPHKKLPYHVMDZ-UHFFFAOYSA-N 0.000 description 7
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 6
- 239000006227 byproduct Substances 0.000 description 6
- 230000015572 biosynthetic process Effects 0.000 description 5
- 238000003786 synthesis reaction Methods 0.000 description 5
- MZPDVYDLHYUTQS-UHFFFAOYSA-N (2-amino-5-methylphenyl)-phenylmethanone Chemical compound CC1=CC=C(N)C(C(=O)C=2C=CC=CC=2)=C1 MZPDVYDLHYUTQS-UHFFFAOYSA-N 0.000 description 4
- WSLDOOZREJYCGB-UHFFFAOYSA-N 1,2-Dichloroethane Chemical compound ClCCCl WSLDOOZREJYCGB-UHFFFAOYSA-N 0.000 description 4
- 238000005160 1H NMR spectroscopy Methods 0.000 description 4
- 0 C*(cc1)ccc1N Chemical compound C*(cc1)ccc1N 0.000 description 4
- RZXMPPFPUUCRFN-UHFFFAOYSA-N p-toluidine Chemical compound CC1=CC=C(N)C=C1 RZXMPPFPUUCRFN-UHFFFAOYSA-N 0.000 description 4
- 238000002390 rotary evaporation Methods 0.000 description 4
- LPXPTNMVRIOKMN-UHFFFAOYSA-M sodium nitrite Chemical compound [Na+].[O-]N=O LPXPTNMVRIOKMN-UHFFFAOYSA-M 0.000 description 4
- ZSTUEICKYWFYIC-UHFFFAOYSA-N 2-(4-methylphenyl)benzoic acid Chemical group C1=CC(C)=CC=C1C1=CC=CC=C1C(O)=O ZSTUEICKYWFYIC-UHFFFAOYSA-N 0.000 description 3
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- PASDCCFISLVPSO-UHFFFAOYSA-N benzoyl chloride Chemical compound ClC(=O)C1=CC=CC=C1 PASDCCFISLVPSO-UHFFFAOYSA-N 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 238000007142 ring opening reaction Methods 0.000 description 3
- ZGQVZLSNEBEHFN-UHFFFAOYSA-N 2-(4-methylphenyl)benzonitrile Chemical group C1=CC(C)=CC=C1C1=CC=CC=C1C#N ZGQVZLSNEBEHFN-UHFFFAOYSA-N 0.000 description 2
- 239000005489 Bromoxynil Substances 0.000 description 2
- KXXOMIPLRDTZCC-UHFFFAOYSA-N Cc(cc1)cc2c1-c(cccc1)c1C2=O Chemical compound Cc(cc1)cc2c1-c(cccc1)c1C2=O KXXOMIPLRDTZCC-UHFFFAOYSA-N 0.000 description 2
- 239000002841 Lewis acid Substances 0.000 description 2
- AFBPFSWMIHJQDM-UHFFFAOYSA-N N-methyl-N-phenylamine Natural products CNC1=CC=CC=C1 AFBPFSWMIHJQDM-UHFFFAOYSA-N 0.000 description 2
- ILUJQPXNXACGAN-UHFFFAOYSA-N O-methylsalicylic acid Chemical compound COC1=CC=CC=C1C(O)=O ILUJQPXNXACGAN-UHFFFAOYSA-N 0.000 description 2
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 2
- WQDUMFSSJAZKTM-UHFFFAOYSA-N Sodium methoxide Chemical compound [Na+].[O-]C WQDUMFSSJAZKTM-UHFFFAOYSA-N 0.000 description 2
- 239000008346 aqueous phase Substances 0.000 description 2
- 239000003054 catalyst Substances 0.000 description 2
- 239000012954 diazonium Substances 0.000 description 2
- 150000001989 diazonium salts Chemical class 0.000 description 2
- 150000007517 lewis acids Chemical class 0.000 description 2
- 239000012071 phase Substances 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 238000006798 ring closing metathesis reaction Methods 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 235000010288 sodium nitrite Nutrition 0.000 description 2
- MFRIHAYPQRLWNB-UHFFFAOYSA-N sodium tert-butoxide Chemical compound [Na+].CC(C)(C)[O-] MFRIHAYPQRLWNB-UHFFFAOYSA-N 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 230000002194 synthesizing effect Effects 0.000 description 2
- RMMXLENWKUUMAY-UHFFFAOYSA-N telmisartan Chemical compound CCCC1=NC2=C(C)C=C(C=3N(C4=CC=CC=C4N=3)C)C=C2N1CC(C=C1)=CC=C1C1=CC=CC=C1C(O)=O RMMXLENWKUUMAY-UHFFFAOYSA-N 0.000 description 2
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 2
- DLYUQMMRRRQYAE-UHFFFAOYSA-N tetraphosphorus decaoxide Chemical compound O1P(O2)(=O)OP3(=O)OP1(=O)OP2(=O)O3 DLYUQMMRRRQYAE-UHFFFAOYSA-N 0.000 description 2
- 239000011592 zinc chloride Substances 0.000 description 2
- 235000005074 zinc chloride Nutrition 0.000 description 2
- JIAARYAFYJHUJI-UHFFFAOYSA-L zinc dichloride Chemical compound [Cl-].[Cl-].[Zn+2] JIAARYAFYJHUJI-UHFFFAOYSA-L 0.000 description 2
- BIWQNIMLAISTBV-UHFFFAOYSA-N (4-methylphenyl)boronic acid Chemical compound CC1=CC=C(B(O)O)C=C1 BIWQNIMLAISTBV-UHFFFAOYSA-N 0.000 description 1
- IMSODMZESSGVBE-UHFFFAOYSA-N 2-Oxazoline Chemical compound C1CN=CO1 IMSODMZESSGVBE-UHFFFAOYSA-N 0.000 description 1
- LFFIEVAMVPCZNA-UHFFFAOYSA-N 2-[4-(bromomethyl)phenyl]benzonitrile Chemical group C1=CC(CBr)=CC=C1C1=CC=CC=C1C#N LFFIEVAMVPCZNA-UHFFFAOYSA-N 0.000 description 1
- JFOGXCVQPLGLLD-UHFFFAOYSA-N 2-[4-(dibromomethyl)phenyl]benzonitrile Chemical group C1=CC(C(Br)Br)=CC=C1C1=CC=CC=C1C#N JFOGXCVQPLGLLD-UHFFFAOYSA-N 0.000 description 1
- RKJHJMAZNPASHY-UHFFFAOYSA-N 2-methylfluorene Natural products C1=CC=C2C3=CC=C(C)C=C3CC2=C1 RKJHJMAZNPASHY-UHFFFAOYSA-N 0.000 description 1
- 229940123413 Angiotensin II antagonist Drugs 0.000 description 1
- 239000002083 C09CA01 - Losartan Substances 0.000 description 1
- 239000004072 C09CA03 - Valsartan Substances 0.000 description 1
- 239000005537 C09CA07 - Telmisartan Substances 0.000 description 1
- UUBWFNDPWDNPTE-UHFFFAOYSA-N Cc1ccc(-c2ccccc2)c(C(O)=O)c1 Chemical compound Cc1ccc(-c2ccccc2)c(C(O)=O)c1 UUBWFNDPWDNPTE-UHFFFAOYSA-N 0.000 description 1
- CUSIRUCBGUBSIN-UHFFFAOYSA-N Cc1ccc(C2C(C#N)=CC=CC2)cc1 Chemical compound Cc1ccc(C2C(C#N)=CC=CC2)cc1 CUSIRUCBGUBSIN-UHFFFAOYSA-N 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- 238000003747 Grignard reaction Methods 0.000 description 1
- 238000005666 Myers alkylation reaction Methods 0.000 description 1
- 238000006411 Negishi coupling reaction Methods 0.000 description 1
- 238000006069 Suzuki reaction reaction Methods 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- GHVZOJONCUEWAV-UHFFFAOYSA-N [K].CCO Chemical compound [K].CCO GHVZOJONCUEWAV-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000002333 angiotensin II receptor antagonist Substances 0.000 description 1
- RQPZNWPYLFFXCP-UHFFFAOYSA-L barium dihydroxide Chemical compound [OH-].[OH-].[Ba+2] RQPZNWPYLFFXCP-UHFFFAOYSA-L 0.000 description 1
- 229910001863 barium hydroxide Inorganic materials 0.000 description 1
- 230000031709 bromination Effects 0.000 description 1
- 238000005893 bromination reaction Methods 0.000 description 1
- AXCZMVOFGPJBDE-UHFFFAOYSA-L calcium dihydroxide Chemical compound [OH-].[OH-].[Ca+2] AXCZMVOFGPJBDE-UHFFFAOYSA-L 0.000 description 1
- 239000000920 calcium hydroxide Substances 0.000 description 1
- 229910001861 calcium hydroxide Inorganic materials 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- 238000010531 catalytic reduction reaction Methods 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 229910000365 copper sulfate Inorganic materials 0.000 description 1
- ORTQZVOHEJQUHG-UHFFFAOYSA-L copper(II) chloride Chemical compound Cl[Cu]Cl ORTQZVOHEJQUHG-UHFFFAOYSA-L 0.000 description 1
- ARUVKPQLZAKDPS-UHFFFAOYSA-L copper(II) sulfate Chemical compound [Cu+2].[O-][S+2]([O-])([O-])[O-] ARUVKPQLZAKDPS-UHFFFAOYSA-L 0.000 description 1
- 238000006880 cross-coupling reaction Methods 0.000 description 1
- 239000012024 dehydrating agents Substances 0.000 description 1
- 238000006193 diazotization reaction Methods 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 238000011031 large-scale manufacturing process Methods 0.000 description 1
- 229960004773 losartan Drugs 0.000 description 1
- KJJZZJSZUJXYEA-UHFFFAOYSA-N losartan Chemical compound CCCCC1=NC(Cl)=C(CO)N1CC1=CC=C(C=2C(=CC=CC=2)C=2[N]N=NN=2)C=C1 KJJZZJSZUJXYEA-UHFFFAOYSA-N 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 229910052763 palladium Inorganic materials 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- FAIAAWCVCHQXDN-UHFFFAOYSA-N phosphorus trichloride Chemical compound ClP(Cl)Cl FAIAAWCVCHQXDN-UHFFFAOYSA-N 0.000 description 1
- BDAWXSQJJCIFIK-UHFFFAOYSA-N potassium methoxide Chemical compound [K+].[O-]C BDAWXSQJJCIFIK-UHFFFAOYSA-N 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- QDRKDTQENPPHOJ-UHFFFAOYSA-N sodium ethoxide Chemical compound [Na+].CC[O-] QDRKDTQENPPHOJ-UHFFFAOYSA-N 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 238000001308 synthesis method Methods 0.000 description 1
- 229960005187 telmisartan Drugs 0.000 description 1
- 229960004699 valsartan Drugs 0.000 description 1
- SJSNUMAYCRRIOM-QFIPXVFZSA-N valsartan Chemical compound C1=CC(CN(C(=O)CCCC)[C@@H](C(C)C)C(O)=O)=CC=C1C1=CC=CC=C1C1=NN=N[N]1 SJSNUMAYCRRIOM-QFIPXVFZSA-N 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
Landscapes
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Description
技术领域technical field
本发明涉及一种沙坦联苯的合成方法。The invention relates to a synthesis method of sartan biphenyl.
背景技术Background technique
2-氰基-4’-甲基联苯(沙坦联苯,Ⅰ)是合成血管紧张素Ⅱ拮抗类药物的关键中间体,如洛沙坦、替米沙坦、缬沙坦、伊贝沙坦等。此类药物具有高效、安全、耐受性好、靶器官保护等特点,发展势头强劲,前景广阔。因此,沙坦联苯合成工艺的改进对整个沙滩类药物的合成研究及生产都具有非常重要的意义。2-cyano-4'-methylbiphenyl (sartan biphenyl, Ⅰ) is a key intermediate in the synthesis of angiotensin Ⅱ antagonist drugs, such as losartan, telmisartan, valsartan, ibe Shatan et al. This type of drug has the characteristics of high efficiency, safety, good tolerance, and target organ protection, and has a strong development momentum and broad prospects. Therefore, the improvement of the synthesis process of sartan biphenyl is of great significance to the synthesis research and production of the whole beach drugs.
目前,合成制备沙坦联苯常用的方法较多,主要有以下几种:(1)Meyer邻茴香酸法,采用水杨酸或邻茴香酸作为原料,应用Meyer反应,经噁唑啉合成沙坦联苯,但其合成路线过长,反应总收率较低。(2)Suzuki偶联法,4-甲基苯硼酸和2-溴苯腈在钯的催化下偶联合成沙坦联苯,由于原料价格昂贵,这条合成路线还只能停留在实验室阶段,尚无法进行工业化大生产。(3)Negishi偶联法,首先通过格式反应制备对甲苯基卤化镁,然后和ZnCl2反应制备有机锌试剂,最后与邻溴苯腈交叉偶联合成沙坦联苯,此合成方法需要制备大量的有机锌试剂,而无水ZnCl2极易吸水导致操作难度比较大,大量金属试剂的加入也会加大分离提纯的难度。(4)催化还原法,由4’-二溴甲基-2-氰基联苯或4’-溴甲基-2-氰基联苯催化加氢脱溴制备沙坦联苯,该法原料是沙坦联苯合成后再溴化合成的,反过来合成显然不合理。At present, there are many commonly used methods for synthesizing and preparing sartan biphenyl, which mainly contain the following: (1) Meyer o-anisic acid method, using salicylic acid or o-anisic acid as raw material, applying Meyer reaction, and synthesizing sartan biphenyl through oxazoline Tanbiphenyl, but its synthetic route is too long, and the overall reaction yield is low. (2) Suzuki coupling method, 4-methylphenylboronic acid and 2-bromoxynil are coupled under the catalysis of palladium to synthesize sartan biphenyl. Due to the high price of raw materials, this synthetic route can only stay in the laboratory stage , it is not yet possible to carry out industrialized large-scale production. (3) Negishi coupling method, first prepare p-tolyl magnesium halide by Grignard reaction, then react with ZnCl to prepare organozinc reagent, finally cross-coupling with o-bromoxynil to synthesize sartan biphenyl, this synthetic method needs to prepare a large amount of Organic zinc reagents, and anhydrous ZnCl2 is extremely easy to absorb water, which makes the operation more difficult, and the addition of a large amount of metal reagents will also increase the difficulty of separation and purification. (4) Catalytic reduction method, preparing sartan biphenyl by catalytic hydrodebromination of 4'-dibromomethyl-2-cyanobiphenyl or 4'-bromomethyl-2-cyanobiphenyl, the raw material of this method It is synthesized by bromination after the synthesis of sartan biphenyl, and the reverse synthesis is obviously unreasonable.
发明内容Contents of the invention
本发明的目的在于提供一种安全、高收率、高纯度的沙坦联苯的合成方法。The object of the present invention is to provide a safe, high-yield, high-purity synthetic method of sartan biphenyl.
本发明的技术解决方案是:Technical solution of the present invention is:
本发明以对甲苯胺(Ⅱ)为原料,与苯甲酰氯(Ⅲ)在路易斯酸催化条件下发生傅克酰基化反应;然后在亚硝酸钠参与下经重氮盐和苯环发生闭环;继而在碱性条件下开环,生成主产物(Ⅵ)和副产物(Ⅶ),将开环产物制成盐进行分离;最后将羧基转化为氰基制得沙坦联苯(Ⅰ)。其合成路线如下:The present invention takes p-toluidine (II) as a raw material, undergoes Friedel-Crafts acylation reaction with benzoyl chloride (III) under Lewis acid catalyzed conditions; then undergoes ring closure through diazonium salt and benzene ring under the participation of sodium nitrite; and then Under alkaline conditions, the ring is opened to generate the main product (VI) and by-product (VII), and the ring-opened product is made into a salt for separation; finally, the carboxyl group is converted into a cyano group to obtain sartan biphenyl (I). Its synthetic route is as follows:
本发明中,傅克酰基化反应所使用的催化剂为路易斯酸,如AlCl3、ZnCl2、或FeCl3等,反应温度为160℃。In the present invention, the catalyst used in the Friedel-Crafts acylation reaction is a Lewis acid, such as AlCl 3 , ZnCl 2 , or FeCl 3 , and the reaction temperature is 160°C.
本发明中,重氮化反应所用的酸为硫酸,所用的溶剂是水。In the present invention, the acid used in the diazotization reaction is sulfuric acid, and the solvent used is water.
本发明中,重氮盐关环所用的催化剂为铜粉、氯化铜,或硫酸铜等。In the present invention, the catalyst used for ring closure of the diazonium salt is copper powder, copper chloride, or copper sulfate.
本发明中,碱性开环使用的碱为氢氧化钠、甲醇钠、乙醇钠、叔丁醇钠、氢氧化钾、甲醇钾、乙醇钾,或叔丁醇钾,叔丁醇钾为最优选择。In the present invention, the alkali used for alkaline ring opening is sodium hydroxide, sodium methylate, sodium ethylate, sodium tert-butoxide, potassium hydroxide, potassium methylate, potassium ethylate, or potassium tert-butoxide, and potassium tert-butoxide is optimal choose.
本发明中,开环产物制成盐进行分离所用的碱为氢氧化镁、氢氧化钡或氢氧化钙等。纯化后废弃的开环产物可在浓硫酸中进行环合回到原料。In the present invention, the alkali used for separating the ring-opened product into a salt is magnesium hydroxide, barium hydroxide or calcium hydroxide. The discarded ring-opened product after purification can be cyclized back to the starting material in concentrated sulfuric acid.
本发明中形成氰基的脱水剂为氯化亚砜、三氯化磷,或五氧化二磷。The dehydrating agent forming cyano group in the present invention is sulfur oxychloride, phosphorus trichloride, or phosphorus pentoxide.
本发明反应条件温和,操作简便,适合工业化生产。The invention has mild reaction conditions, simple and convenient operation, and is suitable for industrial production.
本发明优点:原料易得、安全,便于生产管理;成本较低,减少三废污染;副产物可回收利用,提高原子利用率。The invention has the advantages of easy-to-obtain and safe raw materials, and is convenient for production management; the cost is low, and the pollution of three wastes is reduced; by-products can be recycled, and the utilization rate of atoms is improved.
下面结合实施例对本发明作进一步说明。The present invention will be further described below in conjunction with embodiment.
具体实施方式detailed description
2-氨基-5甲基二苯甲酮的制备(Ⅳ)Preparation of 2-amino-5-methylbenzophenone (Ⅳ)
将苯甲酰氯(133.6mL,1.15mol)置于反应瓶中,搅拌,升温至120℃,缓慢加入对甲苯胺(50.00g,0.46mol),加完后升温至140℃,2小时后加入无水ZnCl2(79.06g,0.58mol),温度升至160℃反应3小时,降温至100℃,加入200mL水,搅拌,冷却后将水层倒出。往反应瓶中的剩余物中加入70%的硫酸150mL,140℃搅拌2小时,冷却后将反应液倒入大量水中,用氨水中和反应液,乙酸乙酯萃取,旋蒸除去乙酸乙酯,固体用95%乙醇重结晶,得黄色固体(79.70g,产率82.2%)。Put benzoyl chloride (133.6mL, 1.15mol) in a reaction flask, stir, heat up to 120°C, slowly add p-toluidine (50.00g, 0.46mol), heat up to 140°C after the addition, and add no Water ZnCl2 (79.06 g, 0.58 mol), the temperature was raised to 160 ° C for 3 hours, the temperature was lowered to 100 ° C, 200 mL of water was added, stirred, and the water layer was poured out after cooling. Add 150mL of 70% sulfuric acid to the residue in the reaction bottle, stir at 140°C for 2 hours, pour the reaction solution into a large amount of water after cooling, neutralize the reaction solution with ammonia water, extract with ethyl acetate, and remove the ethyl acetate by rotary evaporation. The solid was recrystallized from 95% ethanol to obtain a yellow solid (79.70 g, yield 82.2%).
1HNMR(400MHz,CDCl3,ppm)δ:7.64(d,1H),7.54(t,1H),7.47(t,2H),7.23(s,1H),7.13(d,1H),5.91(s,2H),2.18(s,3H)。1HNMR (400MHz, CDCl3, ppm) δ: 7.64(d,1H),7.54(t,1H),7.47(t,2H),7.23(s,1H),7.13(d,1H),5.91(s,2H ), 2.18(s,3H).
2-甲基芴酮的制备(Ⅴ)Preparation of 2-Methylfluorenone (Ⅴ)
将120mL的水、120mL的乙酸和37.8g的硫酸置于反应瓶中,加入2-氨基-5-甲基二苯甲酮(40.00g,0.19mol),搅拌使溶清,随后冷却至0℃,滴加入亚硝酸钠(13.25g,0.19mol)水溶液25mL,滴加完1小时后,加入4g铜粉,升温至80℃,反应2小时。冷却至室温,用二氯甲烷萃取,旋蒸除去溶剂,固体用90%的乙醇重结晶,得黄色固体(30.04g,82.4%)。Put 120mL of water, 120mL of acetic acid and 37.8g of sulfuric acid in a reaction flask, add 2-amino-5-methylbenzophenone (40.00g, 0.19mol), stir to dissolve, then cool to 0°C , 25 mL of sodium nitrite (13.25 g, 0.19 mol) aqueous solution was added dropwise, and 1 hour after the dropwise addition, 4 g of copper powder was added, the temperature was raised to 80° C., and the reaction was carried out for 2 hours. Cool to room temperature, extract with dichloromethane, remove the solvent by rotary evaporation, and recrystallize the solid with 90% ethanol to obtain a yellow solid (30.04 g, 82.4%).
1HNMR(400MHz,DMSO,ppm)δ:7.74(d,1H),7.68(d,1H),7.59(t,2H),7.42(d,2H),7.34(t,1H),2.35(s,3H)。1HNMR(400MHz,DMSO,ppm)δ:7.74(d,1H),7.68(d,1H),7.59(t,2H),7.42(d,2H),7.34(t,1H),2.35(s,3H ).
2-羧基-4’-甲基联苯的制备(Ⅵ)Preparation of 2-carboxy-4'-methylbiphenyl (Ⅵ)
(1)2-甲基芴酮在碱性条件下开环(1) 2-Methylfluorenone ring-opens under alkaline conditions
(a)2-甲基芴酮在氢氧化钾条件下开环(a) 2-Methylfluorenone ring-opening under potassium hydroxide conditions
将氢氧化钾(11.71g,0.21mol)置于反应瓶中,加入25mL甲苯,搅拌加热至110℃,滴加入溶有2-甲基芴酮(10.00g,0.051mol)的40mL的甲苯溶液中,滴加完后继续搅拌反应2h。冷却到室温,加入50mL水,充分搅拌,将混合物转移至分液漏斗中,分去有机相,水相用甲苯萃取,水相用盐酸调pH至4-6,减压过滤,烘干,得白色固体(6.51g,产率60.2%)。(产物中主产物(Ⅵ)所占的比例为50%,副产物(Ⅶ)所占的比例为50%。)Put potassium hydroxide (11.71g, 0.21mol) in a reaction flask, add 25mL of toluene, stir and heat to 110°C, dropwise add 2-methylfluorenone (10.00g, 0.051mol) into 40mL of toluene solution , After the dropwise addition, the stirring reaction was continued for 2h. Cool to room temperature, add 50mL of water, stir well, transfer the mixture to a separatory funnel, separate the organic phase, extract the water phase with toluene, adjust the pH of the water phase to 4-6 with hydrochloric acid, filter under reduced pressure, and dry to obtain White solid (6.51 g, 60.2% yield). (The proportion that main product (VI) accounts for is 50%, and the proportion that by-product (VII) accounts for is 50% in the product.)
(b)2-甲基芴酮在叔丁醇钾条件下开环(b) Ring opening of 2-methylfluorenone under the condition of potassium tert-butoxide
将叔丁醇钾(67.02g,0.60mol)置于反应瓶中,加入800mL四氢呋喃,搅拌使溶清,加入2-甲基芴酮(29.00g,0.15mol),继续搅拌反应1小时后,加入400mL水,搅拌使固体溶解,旋蒸除去四氢呋喃,水相用二氯甲烷萃取,水相用盐酸调pH至4-6,减压过滤,烘干,得白色固体(29.21g,产率91.8%)。(产物中主产物(Ⅵ)所占的比例为60%,副产物(Ⅶ)所占的比例为40%。)Put potassium tert-butoxide (67.02g, 0.60mol) in the reaction flask, add 800mL tetrahydrofuran, stir to dissolve, add 2-methylfluorenone (29.00g, 0.15mol), continue to stir for 1 hour, then add 400mL of water, stirred to dissolve the solid, and the tetrahydrofuran was removed by rotary evaporation, the aqueous phase was extracted with dichloromethane, the pH of the aqueous phase was adjusted to 4-6 with hydrochloric acid, filtered under reduced pressure, and dried to obtain a white solid (29.21g, yield 91.8% ). (The ratio that main product (VI) accounts for is 60%, and the ratio that by-product (VII) accounts for is 40% in the product.)
(2)开环产物的分离(2) Separation of ring-opened products
将叔丁醇钾条件下开环产物(21.22g,0.10mol)和氢氧化镁(2.92g,0.05mol)置于反应瓶中,加入200mL水,加热搅拌至溶清,然后将部分水蒸馏出来使析出少量固体,然后降温至0℃,过滤,滤饼再溶于水中,加盐酸调PH至4-6,析出固体,过滤,烘干,得2-羧基-4’-甲基联苯(8.06g,产率38.0%),纯度达到99%。Put the ring-opened product (21.22g, 0.10mol) and magnesium hydroxide (2.92g, 0.05mol) under the condition of potassium tert-butoxide into a reaction flask, add 200mL of water, heat and stir until it dissolves, and then distill part of the water A small amount of solid precipitated, then cooled to 0°C, filtered, the filter cake was redissolved in water, and the pH was adjusted to 4-6 by adding hydrochloric acid, the solid was precipitated, filtered, and dried to obtain 2-carboxy-4'-methylbiphenyl ( 8.06g, yield 38.0%), the purity reached 99%.
1HNMR(400MHz,CDCl3,ppm)δ:7.95(d,1H),7.57(t,1H),7.38-7.45(m,2H),7.29(s,2H),7.23(d,2H),2.42(s,3H)。1HNMR (400MHz, CDCl3, ppm) δ: 7.95(d, 1H), 7.57(t, 1H), 7.38-7.45(m, 2H), 7.29(s, 2H), 7.23(d, 2H), 2.42(s ,3H).
(3)副产物(Ⅶ)回收得到2-甲基芴酮(3) By-product (VII) reclaims to obtain 2-methylfluorenone
将上述分离所得滤液用盐酸调pH至4-6,析出故体,烘干,得到白色固体(13.09g),为主产物(Ⅵ)和副产物(Ⅶ)的混合物。The filtrate obtained from the above separation was adjusted to pH 4-6 with hydrochloric acid, the old body was precipitated, and dried to obtain a white solid (13.09 g), which was a mixture of main product (VI) and by-product (VII).
将此混合物(13.09g,0.062mol)置于反应瓶中,加入50mL浓硫酸,搅拌,升温至40℃,6小时后加入200mL水,析出黄色固体,过滤,烘干,得到2-甲基芴酮(11.86g,产率98.1%)。Put this mixture (13.09g, 0.062mol) in a reaction flask, add 50mL of concentrated sulfuric acid, stir, raise the temperature to 40°C, add 200mL of water after 6 hours, precipitate a yellow solid, filter, and dry to obtain 2-methylfluorene Ketone (11.86 g, 98.1% yield).
2-氰基-4’-甲基联苯的制备(Ⅰ)Preparation of 2-cyano-4'-methylbiphenyl (Ⅰ)
将2-羧基-4’-甲基联苯(8.48g,0.040mol)置于反应瓶中,加入150mL1,2-二氯乙烷,搅拌,然后加入吡啶(3.21g,0.040mol)和15mL氯化亚砜,加热回流,8小时后旋蒸除去1,2-二氯乙烷和未反应的氯化亚砜。将80mL甲苯加入到剩余物中,搅拌使溶解,滴加50mL浓氨水,常温搅拌8小时,过滤,烘干。将此烘干物重新置于反应瓶中,加入100mL1,2-二氯乙烷和25mL氯化亚砜,加热搅拌至回流,4小时后旋蒸除去1,2-二氯乙烷和未反应的氯化亚砜,剩余物用80%的乙醇重结晶,得到白色固体(6.48g,产率83.8%)。2-carboxy-4'-methylbiphenyl (8.48g, 0.040mol) was placed in a reaction flask, 150mL of 1,2-dichloroethane was added, stirred, and then pyridine (3.21g, 0.040mol) and 15mL of chlorine were added Thionyl chloride was heated to reflux, and 1,2-dichloroethane and unreacted thionyl chloride were removed by rotary evaporation after 8 hours. Add 80mL of toluene to the residue, stir to dissolve, add dropwise 50mL of concentrated ammonia water, stir at room temperature for 8 hours, filter, and dry. Put the dried product back into the reaction flask, add 100mL of 1,2-dichloroethane and 25mL of thionyl chloride, heat and stir to reflux, and after 4 hours, rotary evaporate to remove 1,2-dichloroethane and unreacted thionyl chloride, and the residue was recrystallized with 80% ethanol to obtain a white solid (6.48g, yield 83.8%).
1HNMR(400MHz,CDCl3,ppm)δ:7.75(d,1H),7.63(t,1H),7.40-7.51(m,4H),7.30(d,2H),2.42(s,3H)。1H NMR (400MHz, CDCl3, ppm) δ: 7.75 (d, 1H), 7.63 (t, 1H), 7.40-7.51 (m, 4H), 7.30 (d, 2H), 2.42 (s, 3H).
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410201677.1A CN104003903B (en) | 2014-05-13 | 2014-05-13 | The synthetic method of sartanbiphenyl |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410201677.1A CN104003903B (en) | 2014-05-13 | 2014-05-13 | The synthetic method of sartanbiphenyl |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104003903A CN104003903A (en) | 2014-08-27 |
CN104003903B true CN104003903B (en) | 2016-05-25 |
Family
ID=51364839
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410201677.1A Active CN104003903B (en) | 2014-05-13 | 2014-05-13 | The synthetic method of sartanbiphenyl |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104003903B (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105037134A (en) * | 2015-05-21 | 2015-11-11 | 启东东岳药业有限公司 | Asymmetric diphenic acid isomeride separation method |
CN113773266A (en) * | 2021-09-28 | 2021-12-10 | 公安部物证鉴定中心 | clonazepam-D2 and preparation method thereof |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040058977A1 (en) * | 2002-09-16 | 2004-03-25 | Zongru Guo | Sulfonyl-containing 2,3-diarylindole compounds, methods for making same, and methods of use thereof |
CN101955415B (en) * | 2010-08-20 | 2013-06-19 | 绍兴文理学院 | Method for preparing 2-hydroxyl biphenyl compound |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS63275548A (en) * | 1987-05-02 | 1988-11-14 | Res Inst For Prod Dev | Production of o-aminobenzoyl compound |
-
2014
- 2014-05-13 CN CN201410201677.1A patent/CN104003903B/en active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040058977A1 (en) * | 2002-09-16 | 2004-03-25 | Zongru Guo | Sulfonyl-containing 2,3-diarylindole compounds, methods for making same, and methods of use thereof |
CN101955415B (en) * | 2010-08-20 | 2013-06-19 | 绍兴文理学院 | Method for preparing 2-hydroxyl biphenyl compound |
Non-Patent Citations (4)
Title |
---|
2H-1, 4-苯并二氮-2-酮类HIV-1 转录抑制剂的设计、合成及活性研究;汤雁波等;《药学学报》;20111231;第46卷;第689页Scheme 1 * |
4′-甲基-2-腈基联苯合成;吴卫忠等;《化工进展》;20051231;第24卷(第5期);第553页反应式及4′-甲基-2-腈基联苯合成 * |
Competition in intramolecular arylation of triphenylmethanols;Roger Bolton等;《Journal of the Chemical Society, Perkin Transactions 2》;19861231(第3期);第407页反应条件及第406页表及化合物 * |
Derivatives of 2, 3-diphenylindole;E.Rithchie;《Journal and Proceedings of the Royal Society of New South Wales》;19461231;第80卷;第39页芴合成 * |
Also Published As
Publication number | Publication date |
---|---|
CN104003903A (en) | 2014-08-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101792400B (en) | A kind of synthetic method of agomelatine | |
CN101851193A (en) | A kind of preparation method of 4-trifluoromethyl nicotinic acid | |
CN101412670A (en) | Method for synthesizing loxoprofen sodium | |
CN102786448A (en) | Method of synthesizing belinostat | |
CN111471047A (en) | Method for the selective synthesis of pyrazolo[1,2-a]pyrazolones or 2-acylindole compounds | |
CN103601749A (en) | Synthetic method of 1-alkylpyrazole-4-boronic acid pinacol ester | |
CN103539748A (en) | Method for preparing 5-(3,6-dihydro-2,6-dioxo-4-trifluoromethyl-1(2H)-pyrimidinyl)thiophenol compound | |
CN105622616A (en) | Preparation method of 4-chloropyrrolo[2,3-d]pyrimidine | |
CN102617587A (en) | Synthesis method for 2,3,6,7-triptycene tetracarboxylic dianhydride | |
CN104003903B (en) | The synthetic method of sartanbiphenyl | |
CN102952084A (en) | A kind of synthetic method of 4,6-dichloro-2-methylthio-5-nitropyrimidine | |
CN102126931B (en) | Preparation method of resveratrol | |
CN106905234A (en) | A kind of method for synthesizing the ethoxyquinoline of 6 amino of HKI-272 intermediate 3 cyano group, 4 chlorine 7 | |
CN102432524A (en) | Method for preparing 2-carboxylic acid indole | |
CN103373963B (en) | Intermediate of pazopanib hydrochloride and preparation method thereof | |
CN103450092B (en) | Synthesis method of metronidazole-sulfanilamide derivatives | |
CN102675294A (en) | Method of synthesizing losartan and losartan intermediates | |
CN101723901A (en) | Method for preparing 2-propylbenzimidazole | |
CN104086456A (en) | Synthesis method of sartanbiphenyl | |
CA3029361A1 (en) | New processes for the preparation of vemurafenib | |
CN103387570A (en) | Preparation method of rizatriptan benzoate | |
CN113698349A (en) | Water-phase photocatalytic preparation method of 2- (2-phenyl-2H-indazole-3-yl) acetate compounds | |
CN103804187B (en) | Synthesis method of diethylstilbestrol compound pigeon pea ketonic acid A | |
CN103012292B (en) | Synthetic method of dibenzanthracene [b,f][1,2] diazocine | |
CN105968108B (en) | A kind of method for synthesizing Pabuk former times profit cloth intermediate |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant |